BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2016
View Archived Issues
Amcure treats first patient in phase I/Ib study of AMC-303
Read More
Medivir selects MIV-818 as candidate drug for hepatocellular carcinoma
Read More
Novartis initiates phase I/II trial of BLZ-945 in advanced solid tumors
Read More
OncoVent initiates clinical development program for AR20.5 for the treatment of pancreatic cancer
Read More
Sumitomo Dainippon announces development highlights of second quarter of fiscal 2016
Read More
Discovery and characterization of novel first-generation CFTR corrector GLPG-2222
Read More
Responses seen with anti-fucosyl-GM1 MAb BMS-986012 in small cell lung cancer
Read More
Verastem obtains license to duvelisib
Read More
Galapagos presents promising data for novel CFTR potentiator GLPG-1837
Read More
Bristol-Myers Squibb reflects on milestones of third quarter 2016
Read More
Durect reports first clinical data on DUR-928 in patients with NASH
Read More
Novo Nordisk reflects on accomplishments of third quarter 2016
Read More
MorphoSys and Leo Pharma collaborate to develop therapeutic antibodies in dermatology
Read More
Phase I data reported for TNFRSF4 agonist MEDI-0562 in patients with solid tumors
Read More
AbbVie presents TNF-alpha modulators
Read More
Genomic Health reports clinical validation study results for Oncotype DX Genomic Prostate Score
Read More
FORMA Therapeutics patents HDAC inhibitors
Read More
SIMM reports development of mGlu5 receptor modulators
Read More
Opiant Pharmaceuticals licenses heroin vaccine from WRAIR and NIDA
Read More
Signal Genetics and miRagen Therapeutics enter merger agreement
Read More
EnBiotix acquires AMP Therapeutics' antimicrobial peptide portfolio
Read More
Omeros reports on phase II trial of PPARgamma agonist in heroin-dependent subjects
Read More
Medivir to acquire two Tetralogic oncology programs
Read More
Gilead terminates development of simtuzumab and GS-5745 for ulcerative colitis and Crohn's disease
Read More
Drug discovery company Bridge Medicines launched in partnership with Takeda
Read More
Investigators identify novel causative mutations in mucopolysaccharidosis type IV patients
Read More
ValiRx updates progress of phase II trial of VAL-401
Read More
Therapeutic potential of 177Lu-labeled chimeric antibody NNV-009 in NHL and CLL
Read More